[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603755":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":31,"centralContacts":35,"locations":46,"responsibleParty":60,"collaborators":40,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":40,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":40,"studyType":77,"phases":78,"briefSummary":68,"conditions":80,"keywords":82,"overallStatus":84,"whyStopped":40,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Aswan University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard dose of Hyberbaric Bupivacaine in Elective cesarean section","ACTIVE_COMPARATOR","1- Standard dose group: receiving the typical dose of hyperbaric bupivacaine (12.5 mg hyperbaric bupivacaine + 25 mcg fentanyl).",[13],"Drug: Hyperbaric Bupivacaine HCl 0.5% 12.5 mg",{"label":15,"type":10,"description":16,"interventionNames":17},"Reduced dose group in Elective cesarean section","2- Reduced dose group: receiving a20% reduced dose of hyperbaric bupivacaine (10 mg hyperbaric bupivacaine + 25 mcg fentanyl).",[18],"Drug: Hyperbaric Bupivacaine HCl 0.5% 10 mg",[20,26],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG","Hyperbaric Bupivacaine HCl 0.5% 12.5 mg",[9],[25],"Standard dose of hyperbaric bupivacaine",{"type":21,"name":27,"description":16,"armGroupLabels":28,"otherNames":29},"Hyperbaric Bupivacaine HCl 0.5% 10 mg",[15],[30],"20% reduced dose of hyperbaric bupivacaine",[32],{"name":33,"affiliation":5,"role":34},"Ayman Mohamdy Eldemerdash, consultant","STUDY_DIRECTOR",[36,42],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},"Eman Mahmoud Ismail, Resident","CONTACT","+201141431136",null,"emanmahmoud37@gmail.com",{"name":43,"role":38,"phone":44,"phoneExt":40,"email":45},"Soudy Salah Hammad, consultant","+201014761523","soudi.salah@aswu.edu.eg",[47],{"facility":48,"status":40,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":40},"Aswan university","Aswān","Aswan Governorate","000","Egypt","EG",{"type":55,"coordinates":56},"Point",[57,58],32.89942,24.09082,{"lat":58,"lon":57},{"type":61,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":40,"oldOrganization":40},"PRINCIPAL_INVESTIGATOR","Eman Mahmoud","Resident Doctor","100603755","phase-4-effect-of-a-20-reduction-in-hyperbaric-bupivacaine-dose-on-high-spinal-block-incidence-in-cesarean-delivery-a-risk-stratified-randomized-controlled-trial-100603755",false,"NCT07140640","Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.","Inclusion Criteria:\n\n* • Pregnant women aged 18-45 years.\n\n  * ASA physical status II-III.\n\nExclusion Criteria:\n\n* • Twin pregnancies.\n\n  * Contraindications to spinal anesthesia (e.g., coagulopathy, infection).\n  * Patients with incomplete preoperative data for risk stratification.",true,"FEMALE","18 Years","45 Years",{"count":75,"type":76},333,"ESTIMATED","INTERVENTIONAL",[79],"PHASE4",[81],"Cesarean Section Complications",[83],"cesarean-20% hyperbaric bupivacaine","NOT_YET_RECRUITING","2025-08-22",{"date":87,"type":88},"2025-08-25","ACTUAL",{"date":90,"type":76},"2025-09-15",{"date":92,"type":76},"2026-03-30",{"name":5,"class":6},1]